ELMD Stock Overview
Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Electromed, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$35.14 |
52 Week High | US$35.50 |
52 Week Low | US$9.90 |
Beta | 0.31 |
1 Month Change | 18.92% |
3 Month Change | 53.45% |
1 Year Change | 248.96% |
3 Year Change | 176.69% |
5 Year Change | 231.82% |
Change since IPO | 782.91% |
Recent News & Updates
Recent updates
What Percentage Of Electromed, Inc. (NYSEMKT:ELMD) Shares Do Insiders Own?
Mar 07Is Electromed, Inc.'s (NYSEMKT:ELMD) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 17Should You Be Impressed By Electromed's (NYSEMKT:ELMD) Returns on Capital?
Feb 02Did Electromed, Inc. (NYSEMKT:ELMD) Insiders Sell Shares?
Jan 21Electromed (NYSEMKT:ELMD) Is Growing Earnings But Are They A Good Guide?
Jan 09Here's Why I Think Electromed (NYSEMKT:ELMD) Might Deserve Your Attention Today
Dec 28Electromed, Inc.'s (NYSEMKT:ELMD) Intrinsic Value Is Potentially 90% Above Its Share Price
Dec 16Announcing: Electromed (NYSEMKT:ELMD) Stock Soared An Exciting 405% In The Last Five Years
Dec 04How Is Electromed's (NYSEMKT:ELMD) CEO Paid Relative To Peers?
Nov 22Shareholder Returns
ELMD | US Medical Equipment | US Market | |
---|---|---|---|
7D | 5.5% | 1.3% | -0.8% |
1Y | 249.0% | 15.0% | 25.2% |
Return vs Industry: ELMD exceeded the US Medical Equipment industry which returned 15% over the past year.
Return vs Market: ELMD exceeded the US Market which returned 25.2% over the past year.
Price Volatility
ELMD volatility | |
---|---|
ELMD Average Weekly Movement | 6.4% |
Medical Equipment Industry Average Movement | 8.8% |
Market Average Movement | 6.5% |
10% most volatile stocks in US Market | 18.7% |
10% least volatile stocks in US Market | 3.3% |
Stable Share Price: ELMD has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ELMD's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | 174 | Jim Cunniff | smartvest.com |
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.
Electromed, Inc. Fundamentals Summary
ELMD fundamental statistics | |
---|---|
Market cap | US$299.67m |
Earnings (TTM) | US$6.47m |
Revenue (TTM) | US$57.06m |
45.9x
P/E Ratio5.2x
P/S RatioIs ELMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ELMD income statement (TTM) | |
---|---|
Revenue | US$57.06m |
Cost of Revenue | US$13.34m |
Gross Profit | US$43.72m |
Other Expenses | US$37.25m |
Earnings | US$6.47m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 11, 2025
Earnings per share (EPS) | 0.76 |
Gross Margin | 76.62% |
Net Profit Margin | 11.34% |
Debt/Equity Ratio | 0% |
How did ELMD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/30 22:31 |
End of Day Share Price | 2025/01/30 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Electromed, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Benjamin Haynor | Feltl and Company, Inc. |
Brooks O'Neil | Lake Street Capital Markets, LLC |
James Terwilliger | Northland Capital Markets |